Th1	B:C0242632
and	O
Innate	O
Lymphoid	I:C0086574
Cells	I:C0086574
accumulate	O
in	O
Primary	O
Sclerosing	I:C0566602
Cholangitis	I:C0566602
-	O
associated	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
.	O

Th1	O
and	O
Innate	B:C0086574
Lymphoid	I:C0086574
Cells	I:C0086574
accumulate	O
in	O
Primary	O
Sclerosing	I:C0566602
Cholangitis	I:C0566602
-	O
associated	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
.	O

Th1	O
and	O
Innate	O
Lymphoid	I:C0086574
Cells	I:C0086574
accumulate	O
in	O
Primary	B:C0566602
Sclerosing	I:C0566602
Cholangitis	I:C0566602
-	O
associated	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
.	O

Th1	O
and	O
Innate	O
Lymphoid	I:C0086574
Cells	I:C0086574
accumulate	O
in	O
Primary	O
Sclerosing	I:C0566602
Cholangitis	I:C0566602
-	O
associated	O
Inflammatory	B:C0021390
Bowel	I:C0021390
Disease	I:C0021390
.	O

Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	B:C0008679
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	B:C1711359
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	B:C0009324
colitis	I:C0009324
(	O
ulcerative	O
colitis	I:C0009324
)	O
.	O

Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
)	O
is	O
an	O
idiopathic	O
chronic	I:C0008679
disorder	I:C0008679
of	O
the	O
hepatobiliary	O
system	I:C1711359
associated	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
,	O
mainly	O
ulcerative	O
colitis	I:C0009324
(	O
ulcerative	B:C0009324
colitis	I:C0009324
)	O
.	O

Colitis	B:C0009324
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
and	O
ulcerative	O
colitis	I:C0009324
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
)	O
exhibits	O
characteristic	O
features	O
and	O
is	O
linked	O
to	O
increased	O
colon	O
cancer	O
risk	O
.	O

Colitis	O
in	O
patients	O
with	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
and	O
ulcerative	O
colitis	I:C0009324
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
)	O
exhibits	O
characteristic	O
features	O
and	O
is	O
linked	O
to	O
increased	O
colon	O
cancer	O
risk	O
.	O

Colitis	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
and	O
ulcerative	B:C0009324
colitis	I:C0009324
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
)	O
exhibits	O
characteristic	O
features	O
and	O
is	O
linked	O
to	O
increased	O
colon	O
cancer	O
risk	O
.	O

Colitis	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
and	O
ulcerative	O
colitis	I:C0009324
(	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
)	O
exhibits	O
characteristic	O
features	O
and	O
is	O
linked	O
to	O
increased	O
colon	O
cancer	O
risk	O
.	O

Colitis	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
and	O
ulcerative	O
colitis	I:C0009324
(	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
)	O
exhibits	O
characteristic	O
features	O
and	O
is	O
linked	O
to	O
increased	O
colon	O
cancer	O
risk	O
.	O

Genetic	B:C2827447
studies	I:C2827447
have	O
identified	O
immune	O
-	O
related	O
susceptibility	O
genes	O
that	O
only	O
partially	O
overlap	O
with	O
those	O
involved	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

Genetic	O
studies	I:C2827447
have	O
identified	O
immune	O
-	O
related	O
susceptibility	B:C0012655
genes	O
that	O
only	O
partially	O
overlap	O
with	O
those	O
involved	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

Genetic	O
studies	I:C2827447
have	O
identified	O
immune	O
-	O
related	O
susceptibility	O
genes	B:C0017337
that	O
only	O
partially	O
overlap	O
with	O
those	O
involved	O
in	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

Genetic	O
studies	I:C2827447
have	O
identified	O
immune	O
-	O
related	O
susceptibility	O
genes	O
that	O
only	O
partially	O
overlap	O
with	O
those	O
involved	O
in	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
observations	B:C0700325
suggest	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
observations	O
suggest	O
that	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
observations	O
suggest	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
observations	O
suggest	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
.	O

It	O
remains	O
to	O
be	O
elucidated	O
whether	O
different	O
immune	B:C0243095
-	I:C0243095
mechanisms	I:C0243095
are	O
involved	O
in	O
colitis	O
in	O
these	O
patients	O
.	O

It	O
remains	O
to	O
be	O
elucidated	O
whether	O
different	O
immune	O
-	I:C0243095
mechanisms	I:C0243095
are	O
involved	O
in	O
colitis	B:C0009324
in	O
these	O
patients	O
.	O

We	O
aimed	O
to	O
evaluate	B:C0220825
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	B:C0021853
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	B:C0039194
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	B:C0086574
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	B:C0086574
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	B:C0007613
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

We	O
aimed	O
to	O
evaluate	O
systemic	O
and	O
intestinal	O
T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
(	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
)	O
responses	O
,	O
previously	O
associated	O
to	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
in	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	B:C0178913
samples	I:C0178913
and	O
colorectal	O
biopsies	O
were	O
collected	O
from	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	O
samples	I:C0178913
and	O
colorectal	B:C0555952
biopsies	O
were	O
collected	O
from	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	O
samples	I:C0178913
and	O
colorectal	O
biopsies	B:C0005558
were	O
collected	O
from	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	O
samples	I:C0178913
and	O
colorectal	O
biopsies	O
were	O
collected	O
from	O
patients	O
with	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	O
samples	I:C0178913
and	O
colorectal	O
biopsies	O
were	O
collected	O
from	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	O
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

Blood	O
samples	I:C0178913
and	O
colorectal	O
biopsies	O
were	O
collected	O
from	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
patients	O
with	O
ulcerative	B:C0009324
colitis	I:C0009324
and	O
healthy	O
controls	O
.	O

T	B:C0039194
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
phenotype	O
was	O
analysed	O
by	O
multicolour	O
flow	I:C0016263
cytometry	I:C0016263
.	O

T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	B:C0086574
lymphoid	I:C0086574
cell	I:C0086574
phenotype	O
was	O
analysed	O
by	O
multicolour	O
flow	I:C0016263
cytometry	I:C0016263
.	O

T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
phenotype	O
was	O
analysed	B:C0936012
by	O
multicolour	O
flow	I:C0016263
cytometry	I:C0016263
.	O

T	O
-	I:C0039194
cell	I:C0039194
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
phenotype	O
was	O
analysed	O
by	O
multicolour	B:C0016263
flow	I:C0016263
cytometry	I:C0016263
.	O

Chemokine	B:C0524914
receptor	I:C0524914
(	O
Chemokine	O
receptor	I:C0524914
)	O
profiling	O
of	O
circulating	O
T	O
-	I:C0039194
cell	I:C0039194
s	O
showed	O
decreased	O
CCR6	O
-	I:C0242632
CXCR3	I:C0242632
+	I:C0242632

Chemokine	O
receptor	I:C0524914
(	O
Chemokine	B:C0524914
receptor	I:C0524914
)	O
profiling	O
of	O
circulating	O
T	O
-	I:C0039194
cell	I:C0039194
s	O
showed	O
decreased	O
CCR6	O
-	I:C0242632
CXCR3	I:C0242632
+	I:C0242632

Chemokine	O
receptor	I:C0524914
(	O
Chemokine	O
receptor	I:C0524914
)	O
profiling	B:C0444680
of	O
circulating	O
T	O
-	I:C0039194
cell	I:C0039194
s	O
showed	O
decreased	O
CCR6	O
-	I:C0242632
CXCR3	I:C0242632
+	I:C0242632

Chemokine	O
receptor	I:C0524914
(	O
Chemokine	O
receptor	I:C0524914
)	O
profiling	O
of	O
circulating	O
T	B:C0039194
-	I:C0039194
cell	I:C0039194
s	O
showed	O
decreased	O
CCR6	O
-	I:C0242632
CXCR3	I:C0242632
+	I:C0242632

Chemokine	O
receptor	I:C0524914
(	O
Chemokine	O
receptor	I:C0524914
)	O
profiling	O
of	O
circulating	O
T	O
-	I:C0039194
cell	I:C0039194
s	O
showed	O
decreased	O
CCR6	B:C0242632
-	I:C0242632
CXCR3	I:C0242632
+	I:C0242632

Th1	I:C0242632
cells	I:C0242632
in	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
but	O
increased	O
CCR6	O
-	I:C0242633
CCR4	I:C0242633
+	I:C0242633

Th1	I:C0242632
cells	I:C0242632
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
,	O
but	O
increased	O
CCR6	O
-	I:C0242633
CCR4	I:C0242633
+	I:C0242633

Th1	I:C0242632
cells	I:C0242632
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
,	O
but	O
increased	O
CCR6	B:C0242633
-	I:C0242633
CCR4	I:C0242633
+	I:C0242633

Th2	I:C0242633
cells	I:C0242633
only	O
in	O
ulcerative	B:C0009324
colitis	I:C0009324
,	O
while	O
increased	O
CCR6	O
+CCR4	I:C2936411
+	I:C2936411

Th2	I:C0242633
cells	I:C0242633
only	O
in	O
ulcerative	O
colitis	I:C0009324
,	O
while	O
increased	O
CCR6	B:C2936411
+CCR4	I:C2936411
+	I:C2936411

Increased	O
frequencies	O
of	O
IFN	B:C0021745
-γ	I:C0021745
secreting	O
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	B:C1327616
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	O
T	B:C0039194
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	O
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	B:C0009368
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	O
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	O
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
compared	O
to	O
ulcerative	O
colitis	I:C0009324
.	O

Increased	O
frequencies	O
of	O
IFN	O
-γ	I:C0021745
secreting	O
T	O
-	I:C0039194
cells	I:C0039194
were	O
found	O
in	O
the	O
colon	O
of	O
patients	O
with	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
compared	O
to	O
ulcerative	B:C0009324
colitis	I:C0009324
.	O

Interestingly	O
,	O
we	O
observed	O
accumulation	B:C4055506
of	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
in	O
the	O
colon	O
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
.	O

Interestingly	O
,	O
we	O
observed	O
accumulation	O
of	O
innate	B:C0086574
lymphoid	I:C0086574
cell	I:C0086574
in	O
the	O
colon	O
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
.	O

Interestingly	O
,	O
we	O
observed	O
accumulation	O
of	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
in	O
the	O
colon	B:C0009368
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
.	O

Interestingly	O
,	O
we	O
observed	O
accumulation	O
of	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
in	O
the	O
colon	O
in	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
.	O

Interestingly	O
,	O
we	O
observed	O
accumulation	O
of	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
in	O
the	O
colon	O
in	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
.	O

Our	O
study	B:C2603343
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	B:C0021053
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	B:C0009324
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	B:C0021853
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	B:C0242632
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	B:C0086574
lymphoid	I:C0086574
cell	I:C0086574
responses	O
.	O

Our	O
study	O
suggests	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
represent	O
a	O
different	O
immunological	O
disorder	I:C0021053
from	O
ulcerative	O
colitis	I:C0009324
,	O
characterised	O
by	O
increased	O
intestinal	O
Th1	O
and	O
innate	O
lymphoid	I:C0086574
cell	I:C0086574
responses	B:C0007613
.	O

These	O
results	O
provide	O
further	O
evidence	O
that	O
Primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
results	O
provide	O
further	O
evidence	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	B:C0009324
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
.	O

These	O
results	O
provide	O
further	O
evidence	O
that	O
Primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
-	O
ulcerative	O
colitis	I:C0009324
may	O
represent	O
a	O
distinct	O
form	O
of	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
.	O

